Literature DB >> 12976976

Effect of Acthar-c (ACTH) in sarcoidosis.

M A MILLER, H E BASS.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; SARCOIDOSIS/therapy

Mesh：

Substances：

Year:  1952        PMID： 12976976     DOI： 10.7326/0003-4819-37-4-776

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study.

Authors:  Marc A Judson; Aakash Modi; Furqan Ilyas; Recai Yucel
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 2.  Treatment of Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

3.  Repository corticotropin for Chronic Pulmonary Sarcoidosis.

Authors:  Robert P Baughman; Nadera Sweiss; Ruth Keijsers; Surinder S Birring; Ralph Shipley; Lesley Ann Saketkoo; Elyse E Lower
Journal:  Lung       Date:  2017-03-28       Impact factor: 2.584

4.  Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel.

Authors:  Ying Zhou; Elyse E Lower; Huiping Li; Robert P Baughman
Journal:  Respir Med Case Rep       Date:  2015-11-19

Review 5.  Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.

Authors:  Mehdi Mirsaeidi; Robert P Baughman
Journal:  Pulm Ther       Date:  2022-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.